Real World Experience

Russo Partners has a history. From the evolution of biotech to the launch of pharmaceutical marketing 2.0, we have been there every step of the way.

We’re not all talk. PR isn’t just about getting a message out. It’s getting the right message to the right people at the right time. At Russo Partners, we do just that – and so much more.

At Russo Partners, communications counselors with PhDs, MDs, JDs and MBAs roll up their sleeves to implement integrated programs for biopharma, medtech, diagnostics, healthcare IT and healthcare services companies worldwide.

Since our founding as Noonan/Russo more than 25 years ago, we’ve been on a first-name basis with the people you need to be talking to. Which means you should be talking to us.

Latest News

 

Jul
26

Pharnext Announces the Appointment of René Goedkoop as Chief Medical Officer and François Chamoun as General Counsel

Paris, July 26, 2016 – Pharnext (ISIN FR00111911287), a French biopharmaceutical company developing an advanced portfolio of products in theREAD MORE…

Jul
19

Alder BioPharmaceuticals to Host Conference Call to Discuss Second Quarter 2016 Financial and Operating Results

BOTHELL, Wash., July 19, 2016 (GLOBE NEWSWIRE) — Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics,READ MORE…

Jul
18

DalCor’s Dalcetrapib Demonstrates Genotype-Dependent Effects on Cholesterol Efflux and Inflammation in Data Published by The Montreal Heart Institute in Circulation Cardiovascular Genetics

Effects on C-reactive protein and cholesterol efflux support dalcetrapib benefits on cardiovascular outcomes in patients with AA genotype of ADCY9READ MORE…

Twitter Stream